Ignite Creation Date:
2024-05-05 @ 11:28 AM
Last Modification Date:
2024-10-26 @ 9:08 AM
Study NCT ID:
NCT00055471
Status:
COMPLETED
Last Update Posted:
2012-10-31
First Post:
2003-03-03
Brief Title:
A Phase IIa Open-label Multicenter Dose-escalation Study to Assess the Tolerability and Pharmacokinetics of ZD4054 Zibotentan Given Orally Once Daily in Subjects With Metastatic Prostate Cancer
Sponsor:
Organization:
AstraZeneca